Hinova Pharmaceuticals Inc. (SHA:688302)

Hinova Pharmaceuticals Statistics

Total Valuation

SHA:688302 has a market cap or net worth of CNY 4.76 billion. The enterprise value is 3.95 billion.

Market Cap	4.76B
Enterprise Value	3.95B

Important Dates

The next estimated earnings date is Saturday, April 25, 2026.

Earnings Date	Apr 25, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688302 has 99.02 million shares outstanding. The number of shares has increased by 0.82% in one year.

Current Share Class	99.02M
Shares Outstanding	99.02M
Shares Change (YoY)	+0.82%
Shares Change (QoQ)	-1.30%
Owned by Insiders (%)	20.29%
Owned by Institutions (%)	20.59%
Float	70.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	201.65
PB Ratio	4.32
P/TBV Ratio	4.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-27.32
EV / Sales	167.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.12

Financial Position

The company has a current ratio of 6.90, with a Debt / Equity ratio of 0.10.

Current Ratio	6.90
Quick Ratio	6.54
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.65
Interest Coverage	-403.93

Financial Efficiency

Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is -8.65%.

Return on Equity (ROE)	-12.40%
Return on Assets (ROA)	-7.65%
Return on Invested Capital (ROIC)	-8.65%
Return on Capital Employed (ROCE)	-13.87%
Weighted Average Cost of Capital (WACC)	4.23%
Revenue Per Employee	135,683
Profits Per Employee	-830,870
Employee Count	174
Asset Turnover	0.02
Inventory Turnover	0.76

Taxes

In the past 12 months, SHA:688302 has paid 6,389 in taxes.

Income Tax	6,389
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.20% in the last 52 weeks. The beta is 0.01, so SHA:688302's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	+67.20%
50-Day Moving Average	49.80
200-Day Moving Average	50.84
Relative Strength Index (RSI)	38.30
Average Volume (20 Days)	1,988,994

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688302 had revenue of CNY 23.61 million and -144.57 million in losses. Loss per share was -1.45.

Revenue	23.61M
Gross Profit	23.27M
Operating Income	-169.49M
Pretax Income	-144.57M
Net Income	-144.57M
EBITDA	-167.57M
EBIT	-169.49M
Loss Per Share	-1.45

Balance Sheet

The company has 917.05 million in cash and 106.67 million in debt, with a net cash position of 810.38 million or 8.18 per share.

Cash & Cash Equivalents	917.05M
Total Debt	106.67M
Net Cash	810.38M
Net Cash Per Share	8.18
Equity (Book Value)	1.10B
Book Value Per Share	11.12
Working Capital	834.09M

Cash Flow

In the last 12 months, operating cash flow was -126.81 million and capital expenditures -36.93 million, giving a free cash flow of -163.74 million.

Operating Cash Flow	-126.81M
Capital Expenditures	-36.93M
Free Cash Flow	-163.74M
FCF Per Share	-1.65

Margins

Gross Margin	98.56%
Operating Margin	-717.90%
Pretax Margin	-612.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SHA:688302 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.82%
Shareholder Yield	-0.82%
Earnings Yield	-3.04%
FCF Yield	-3.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688302 has an Altman Z-Score of 8.42 and a Piotroski F-Score of 3.

Altman Z-Score	8.42
Piotroski F-Score	3